Stay updated on QBW251 Dose-range Efficacy & Safety in COPD Clinical Trial

Sign up to get notified when there's something new on the QBW251 Dose-range Efficacy & Safety in COPD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the QBW251 Dose-range Efficacy & Safety in COPD Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now presents the study record for Novartis’s completed Phase 2 QBW251 dose-range trial in people with COPD, including study methods, outcome measures, participant eligibility, locations, and documents.
    Difference
    100%
    Check dated 2026-11-10T06:50:08.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changed from v3.7.2 to v3.8.0. The study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T06:35:31.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-20T08:44:35.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-13T10:18:24.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content, replacing the usual trial details with an error screen. This indicates restricted access to the trial information rather than a metadata change.
    Difference
    18%
    Check dated 2026-09-22T12:38:55.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Revision: v3.6.6 updates the page version from v3.6.5 to v3.6.6. This change signals a newer build of the page and does not appear to alter study content or user-facing details.
    Difference
    0.0%
    Check dated 2026-08-31T23:59:58.000Z thumbnail image

Stay in the know with updates to QBW251 Dose-range Efficacy & Safety in COPD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the QBW251 Dose-range Efficacy & Safety in COPD Clinical Trial page.